Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a COVID pill ease the lingering misery of long haulers?

NCT ID NCT05965726

Summary

This study tested if the antiviral medication Paxlovid could help people suffering from Long COVID. Nearly 1,000 participants were randomly assigned to receive either Paxlovid or a placebo control for different lengths of time. Researchers measured if the treatment improved specific clusters of symptoms, including brain fog, dizziness upon standing, and severe fatigue after exertion.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • All sites listed under NCT05595369

    Durham, North Carolina, 27710, United States

Conditions

Explore the condition pages connected to this study.